Moreover, while RET expression is strongly correlated with that of ER in luminal breast cancers, it lacks prognostic significance as an independent biomarker in breast cancer patient tissue (142), suggesting that additional studies are required to determine if targeting RET will yield clinical benefit in luminal breast cancer patients. Here, ESR1 is linked to breast cancer.